The phase 2 REST trial by Frida Bugge Askeland and colleagues, reported in The Lancet Haematology, provides insight into ...

Dogecoin price rally fuels market excitement as this potential rival gains traction, targeting a surge from $0.10 to $1 ...

Single dose relabotulinumtoxinA demonstrated rapid onset, long-lasting duration of aesthetic efficacy and high patient ...

Holders Al-Ain slumped out of the Asian Champions League Elite on Monday as the side from the United Arab Emirates lost 2-1 to Qatar's Al-Rayyan to end their hopes of a place in the last 16 with one ...

The expectations have been set for the Giants to become more competitive next season, and here’s a few ways they can do so beyond personnel changes.

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

Starting Tuesday, nearly all imports from Canada and Mexico will be charged a 25% tariff, while goods from China will be ...

Horses trained by Bob Baffert hold the top spots on both the Kentucky Derby and Kentucky Oaks leaderboards after weekend wins ...

Wong, Founder and CEO of HCW Biologics, commented, “The FDA’s clearance to initiate our first-in-human clinical trial for HCW9302 brings us one step closer to advancing a potentially transformative ...

Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total addressable global market ...

Invivyd (IVVD) announced positive data from its ongoing Phase 1/2 clinical trial of VYD2311, Invivyd’s novel monoclonal antibody candidate ...